Checks and balances between human cytomegalovirus replication and indoleamine-2,3- dioxygenase

Journal of General Virology

Volumn 95, Issue PART3, 2014, Pages 659-670

  Zimmermann, Albert ^a   Hauka, Sebastian ^a   Maywald, Marco ^a   Le, Vu Thuy Khanh ^b   Schmidt, Silvia K ^a   Däubener, Walter ^a   Hengel, Hartmut ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; VIRUS REPLICATION;

EID: 84894035421     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.061994-0     Document Type: Article

References (47)

1. Adair, R., Liebisch, G. W., Lerman, B. J. & Colberg-Poley, A. M. (2006). Human cytomegalovirus temporally regulated gene expression in differentiated, immortalized retinal pigment epithelial cells. J Clin Virol 35, 478-484.
2. Adams, O., Besken, K., Oberdörfer, C., MacKenzie, C. R., Rüssing, D. & Däubener, W. (2004a). Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase. Microbes Infect 6, 806-812.
3. Adams, O., Besken, K., Oberdörfer, C., MacKenzie, C. R., Takikawa, O. & Däubener, W. (2004b). Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. J Virol 78, 2632-2636.
4. Atalay, R., Zimmermann, A., Wagner, M., Borst, E., Benz, C., Messerle, M. & Hengel, H. (2002). Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 76, 8596-8608.
5. Baron, M. & Davignon, J. L. (2008). Inhibition of IFN-gammainduced STAT1 tyrosine phosphorylation by human CMV is mediated by SHP2. J Immunol 181, 5530-5536.
6. Bodaghi, B., Goureau, O., Zipeto, D., Laurent, L., Virelizier, J. L. & Michelson, S. (1999a). Role of IFN-gamma-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J Immunol 162, 957-964.
7. Bodaghi, B., Slobbe-van Drunen, M. E., Topilko, A., Perret, E., Vossen, R. C., van Dam-Mieras, M. C., Zipeto, D., Virelizier, J. L., LeHoang, P. & other authors (1999b). Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis. Invest Ophthalmol Vis Sci 40, 2598-2607.
8. Borst, E. & Messerle, M. (2000). Development of a cytomegalovirus vector for somatic gene therapy. Bone Marrow Transplant 25 (Suppl 2), S80-S82.
9. Chaumorcel, M., Lussignol, M., Mouna, L., Cavignac, Y., Fahie, K., Cotte-Laffitte, J., Geballe, A., Brune, W., Beau, I. & other authors (2012). The human cytomegalovirus protein TRS1 inhibits autophagy via its interaction with Beclin 1. J Virol 86, 2571-2584.
10. Darnell Jr J. E.,(1997). STATs and gene regulation. Science 277, 1630-1635.
11. Däubener, W., Spors, B., Hucke, C., Adam, R., Stins, M., Kim, K. S. & Schroten, H. (2001). Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. Infect Immun 69, 6527-6531.
12. Detrick, B., Rhame, J., Wang, Y., Nagineni, C. N. & Hooks, J. J. (1996). Cytomegalovirus replication in human retinal pigment epithelial cells. Altered expression of viral early proteins. Invest Ophthalmol Vis Sci 37, 814-825.
13. Fougeray, S., Mami, I., Bertho, G., Beaune, P., Thervet, E. & Pallet, N. (2012). Tryptophan depletion and the kinase GCN2 mediate IFN-cinduced autophagy. J Immunol 189, 2954-2964.
14. Gelderman, A. H., Grimley, P. M., Lunde, M. N. & Rabson, A. S. (1968). Toxoplasma gondii and cytomegalovirus: mixed infection by a parasite and a virus. Science 160, 1130-1132.
15. Halenius, A., Hauka, S., Dölken, L., Stindt, J., Reinhard, H., Wiek, C., Hanenberg, H., Koszinowski, U. H., Momburg, F. & Hengel, H. (2011). Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription. J Virol 85, 3473-3485.
16. Hegde, N. R. & Johnson, D. C. (2003). Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells. J Virol 77, 9287-9294.
17. Hegde, N. R., Tomazin, R. A., Wisner, T. W., Dunn, C., Boname, J. M., Lewinsohn, D. M. & Johnson, D. C. (2002). Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. J Virol 76, 10929-10941.
18. Hengel, H., Esslinger, C., Pool, J., Goulmy, E. & Koszinowski, U. H. (1995). Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol 76, 2987-2997.
19. Heseler, K., Schmidt, S. K., Spekker, K., Sinzger, C., Sorg, R. V., Quambusch, M., Zimmermann, A., Meisel, R. & Däubener, W. (2013). Cytomegalovirus impairs the induction of indoleamine 2,3-dioxygenase mediated antimicrobial and immunoregulatory effects in human fibroblasts. PLoS ONE 8, e64442.
20. Khan, S., Zimmermann, A., Basler, M., Groettrup, M. & Hengel, H. (2004). A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction. J Virol 78, 1831-1842.
21. Knoblach, T., Grandel, B., Seiler, J., Nevels, M. & Paulus, C. (2011). Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ. PLoS Pathog 7, e1002016.
22. Le, V. T., Trilling, M., Wilborn, M., Hengel, H. & Zimmermann, A. (2008). Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. J Gen Virol 89, 2416-2426.
23. Lopez, H., Benard, M., Saint-Aubert, E., Baron, M., Martin, H., Al Saati, T., Plantavid, M., Duga-Neulat, I., Berrebi, A. & other authors (2011). Novel model of placental tissue explants infected by cytomegalovirus reveals different permissiveness in early and term placentae and inhibition of indoleamine 2,3-dioxygenase activity. Placenta 32, 522-530.
24. MacKenzie, C. R., Hadding, U. & Däubener, W. (1998). Interferongamma- induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci. J Infect Dis 178, 875-878.
25. MacKenzie, C. R., Heseler, K., Müller, A. & Däubener, W. (2007). Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. Curr Drug Metab 8, 237-244.
26. McFarlane, S., Aitken, J., Sutherland, J. S., Nicholl, M. J., Preston, V. G. & Preston, C. M. (2011). Early induction of autophagy in human fibroblasts after infection with human cytomegalovirus or herpes simplex virus 1. J Virol 85, 4212-4221.
27. Meisel, R., Zibert, A., Laryea, M., Göbel, U., Däubener, W. & Dilloo, D. (2004). Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103, 4619-4621.
28. Meisel, R., Brockers, S., Heseler, K., Degistirici, O., Bülle, H., Woite, C., Stuhlsatz, S., Schwippert, W., Jäger, M. & other authors (2011). Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 25, 648-654.
29. Miller, D. M., Rahill, B. M., Boss, J. M., Lairmore, M. D., Durbin, J. E., Waldman, J. W. & Sedmak, D. D. (1998). Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 187, 675-683.
30. Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A. & Mellor, A. L. (1999). Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189, 1363-1372.
31. Obojes, K., Andres, O., Kim, K. S., Däubener, W. & Schneider-Schaulies, J. (2005). Indoleamine 2,3-dioxygenase mediates cell typespecific anti-measles virus activity of gamma interferon. J Virol 79, 7768-7776.
32. Orabona, C., Pallotta, M. T. & Grohmann, U. (2012). Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase. Mol Med 18, 834-842.
33. Pallotta, M. T., Orabona, C., Volpi, C., Vacca, C., Belladonna, M. L., Bianchi, R., Servillo, G., Brunacci, C., Calvitti, M. & other authors (2011). Indoleamine 2,3-dioxygenase is a signaling protein in longterm tolerance by dendritic cells. Nat Immunol 12, 870-878.
34. Paulus, C., Krauss, S. & Nevels, M. (2006). A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc Natl Acad Sci U S A 103, 3840-3845.
35. Sarkis, P. T., Ying, S., Xu, R. & Yu, X. F. (2006). STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha. J Immunol 177, 4530-4540.
36. Schroder, K., Hertzog, P. J., Ravasi, T. & Hume, D. A. (2004). Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75, 163-189.
37. Schroten, H., Spors, B., Hucke, C., Stins, M., Kim, K. S., Adam, R. & Däubener, W. (2001). Potential role of human brain microvascular endothelial cells in the pathogenesis of brain abscess: inhibition of Staphylococcus aureus by activation of indoleamine 2,3-dioxygenase. Neuropediatrics 32, 206-210.
38. Sinzger, C., Schmidt, K., Knapp, J., Kahl, M., Beck, R., Waldman, J., Hebart, H., Einsele, H. & Jahn, G. (1999). Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J Gen Virol 80, 2867-2877.
39. Sinzger, C., Hahn, G., Digel, M., Katona, R., Sampaio, K. L., Messerle, M., Hengel, H., Koszinowski, U., Brune, W. & Adler, B. (2008). Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol 89, 359-368.
40. Soliman, H., Mediavilla-Varela, M. & Antonia, S. (2010). Indoleamine 2,3-dioxygenase: is it an immune suppressor? Cancer J 16, 354-359.
41. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H. & Schreiber, R. D. (1998). How cells respond to interferons. Annu Rev Biochem 67, 227-264.
42. Takikawa, O., Kuroiwa, T., Yamazaki, F. & Kido, R. (1988). Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J Biol Chem 263, 2041-2048.
43. Terajima, M. & Leporati, A. M. (2005). Role of indoleamine 2,3- dioxygenase in antiviral activity of interferon-gamma against vaccinia virus. Viral Immunol 18, 722-729.
44. Tomazin, R., Boname, J., Hegde, N. R., Lewinsohn, D. M., Altschuler, Y., Jones, T. R., Cresswell, P., Nelson, J. A., Riddell, S. R. & Johnson, D. C. (1999). Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med 5, 1039-1043.
45. Trilling, M., Le, V. T. & Hengel, H. (2012). Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention. Future Microbiol 7, 1269-1282.
46. Wagner, M. & Koszinowski, U. H. (2004). Mutagenesis of viral BACs with linear PCR fragments (ET recombination). Methods Mol Biol 256, 257-268.
47. Zimmermann, A. & Hengel, H. (2006). Cytomegalovirus interference with interferons. In Cytomegaloviruses: Molecular Biology and Immunology, pp. 321-339. Edited by M. J. Reddehase. Norfolk, UK: Caister Academic Press.